The guidelines provide a framework for physicians to tailor the diagnostic process to individual patient needs, according to a Dec. 23 news release from the Alzheimer’s Association.
The framework includes a three-step formula of assessing cognitive function, behavior and identifying underlying conditions that could be contributing to the symptoms a patient is experiencing. Results from the assessment can then be used to establish a care plan, the release said.
The formula is designed to allow for the integration of new testing and biomarker technologies as the field continues to evolve.
Three guideline updates were published Dec. 23 in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association. Read the guidelines for primary care here, for specialty care here and for validated clinical assessment instruments here.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
